Issue Lab
Every day, the more than 900,000 biopharmaceutical industry employees across the United States work to research, develop and manufacture lifesaving medicines and treatments. It is important to have public policies that encourage and support continued medical innovation, while also improving patient access to affordable medicines.
We aim to protect access, innovation and jobs.
Unfortunately, some policymakers have proposed policies that would chill investment in science, threaten access to medicines and put jobs at risk.
View Issues
Employee Champions
Meet the recipients of the 2022 Employee Champions Awards. This award recognizes individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need.
Rohit Bansal
Commercial Lead for Digital Therapeutics
Otsuka America Pharmaceutical, Inc.
Doug Clark
Director of U.S. Pricing Analytics
Merck
Victoria Diab
Associate Clinical Scientist
Bristol Myers Squibb
Kate Hashey
Director of Vaccines Government Affairs
GSK
Lori Magnoni
Director of Market Access Strategy
Astellas
Dr. Raja Mangipudy
Head of WRDM Drug Safety Research and Development and Comparative Medicine
Pfizer
Kathryn Mathias
Associate Director, Launch Excellence
Takeda Pharmaceuticals America, Inc.
Stephen Mayclin
Crystallography Lead
UCB
Dr. Abena Osei-Wusu
Medical Director of Atherosclerosis
Novartis
Deborah Reardon
Director of Access Solutions
Boehringer Ingelheim
Lisa Shea, MPH & RD
Scientific Patient Engagement Leader
J&J
Kate Wilson
Head of Health Equity for Patient Engagement, Equity and Transparency
Biogen